Diagnostics & biomarkers

Ebola Is Killing People Before The System Finds Them.

Parkinson’s Gets Fast Track, Not Fast Proof

ctDNA Is Becoming a Surveillance Policy, Not Just a Test

AI Wants to Choose Pancreatic Chemo

ALS Biomarkers Are Entering the Approval Fight

Alzheimer’s Pill Has Finished the Trial. Evidence Has Not.

The Cyclospora Test Was Wrong. Public Trust Cannot Be

The weight came back. Some visceral fat did not. Obesity care may be measuring the wrong outcome

Prevention Is Now Alzheimer’s Hardest Trial
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
